The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 49 | 6.2x | 20.1x | Near average | |
Growth | 95 | — | 5.6% | Above average | |
Quality | 58 | -54.5% | 7.6% | Near average | |
Safety | 84 | -2.2x | 0.4x | Above average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Q32 Bio Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Q32 Bio Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The target forecasts for QTTB have seen price stability at an average of 13.5 dollars; however, the fundamental change lies in the shrinking base of analysts following the stock from 3 to only 2 analysts over the past 30 days. This decrease in the number of coverages indicates a decline in the level of certainty or institutional interest in the stock, despite the price target remaining constant with a narrow gap between the high (14 dollars) and low (13 dollars), reflecting Low Dispersion among the remaining analysts.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.